AGFB Agfa-Gevaert NV

Publication of a transparency notification – Regulated information

Publication of a transparency notification – Regulated information

                                       

                                       

Publication of a transparency notification – Regulated information

(Article 14 of the law of May 2, 2007 on the disclosure of significant shareholdings)

Mortsel, Belgium – November 4, 2024 – 5:45 p.m. CET



According to Agfa-Gevaert NV’s bylaws, the threshold as from which a shareholding needs to be disclosed, has been set at 3%, 5% and a multiple of 5%.

In conformity with the Law of May 2, 2007 regarding the disclosure of significant shareholdings in listed companies, Agfa-Gevaert (Euronext: AGFB) discloses the following declaration:

Axxion SA declared on October 31, 2024, that as per October 29, 2024, it holds a stake in Agfa-Gevaert of 7,725,277 shares or 4.99% (denominator is 154,820,528), thus crossing the 5% threshold downwards. As of July 2, 2021, Axxion SA held a stake in Agfa-Gevaert of 8,502,294 voting rights, or 5.13%

Additional information

Axxion SA is the management company and in some cases the asset manager of the funds holding the Agfa position. Nevertheless, the management company exercises the voting rights at its discretions in the absence of specific instructions.

Notifications of important shareholdings to be made according to the Law of May 2, 2007 or Agfa-Gevaert NV’s bylaws, should be sent to .

About Agfa-Gevaert

The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds three divisions: Radiology Solutions, HealthCare IT and Digital Print & Chemicals. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2023, the Group realized a turnover of 1,150 million euro.

Contact:

Viviane Dictus

Director Corporate Communications

tel. 4

e-mail:

Attachment



EN
04/11/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Agfa-Gevaert NV

Agfa-Gevaert NV: 1 director

A director at Agfa-Gevaert NV bought 80,000 shares at 0.681EUR and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearl...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Agfa-Geveart: Material miss on Healthcare activities. ASML: Long-term guidance confirmed. CVC Capital Partners: Comfortably on track. DEME Group: Raises outlook, lowers capex guidance. Proximus: Pressure on CEO from another possible coalition party. SBM Offshore: Again delivering

Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Thibault Leneeuw
  • Wim Lewi
Guy Sips
  • Guy Sips

Agfa 3Q24 below forecasts & €50m savings program to align the cost bas...

3Q24 numbers were below our and CSS forecasts. We will update our model but we already lower our Target Price from € 2.0 to € 1.4. 3Q24 sales came in at € 277m (KBCSe € 291, CSS 286) and 3Q24 REBIT was €4m (KBCSe € 8.1m, CSS € 7m) with especially a poor performance in Radiology Solutions. Agfa hinted at a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. Thi...

 PRESS RELEASE

The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 1...

The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro - regulated information                                         Regulated information November 14, 2024 - 7:45 a.m. CET        The Agfa-Gevaert Group in Q3 2024: stable sales, adjusted EBITDA at 15 million euro The Agfa-Gevaert Group posted double-digit revenue growth and a strong profitability step up in Digital Printing and Chemicals, and a significant increase in order intake in HealthCare IT, with a high share of cloud-based and net new customer contracts. This was counterbalanced by an accelerated m...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch